BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26124342)

  • 1. Expression of the Epithelial Cell Adhesion Molecule and Cytokeratin 8 in Head and Neck Squamous Cell Cancer: A Comparative Study.
    Andratschke M; Hagedorn H; Nerlich A
    Anticancer Res; 2015 Jul; 35(7):3953-60. PubMed ID: 26124342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
    Andratschke M; Luebbers CW; Johannson V; Schmitt B; Mack B; Zeidler R; Lang S; Wollenberg B; Gildehaus FJ
    Anticancer Res; 2011 Oct; 31(10):3315-21. PubMed ID: 21965741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
    Hristozova T; Konschak R; Budach V; Tinhofer I
    Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer.
    Andratschke M; Hagedorn H; Luebbers CW; Schmitt B; Lang S; Zeidler R; Wollenberg B
    Anticancer Res; 2006; 26(1A):153-8. PubMed ID: 16475692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer.
    Trivedi S; Mattos J; Gooding W; Godfrey TE; Ferris RL
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):261-8. PubMed ID: 23625795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Junctional Adhesion Molecule-A in Head and Neck Squamous Cell Carcinoma.
    Kurose M; Kakuki T; Takano K; Kondo A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Kojima T; Himi T
    Adv Otorhinolaryngol; 2016; 77():92-7. PubMed ID: 27115511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
    Wang Y; Chen C; Wang X; Jin F; Liu Y; Liu H; Li T; Fu J
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2461-2468. PubMed ID: 27601166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck.
    Gires O; Mack B; Rauch J; Matthias C
    Biochem Biophys Res Commun; 2006 Apr; 343(1):252-9. PubMed ID: 16540085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
    Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
    Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
    Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
    Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative expression study of four cytokeratins and p63 in squamous cell carcinoma of the tongue: suitability for sentinel node navigation surgery using one-step nucleic acid amplification.
    Yamauchi K; Fujioka Y; Kogashiwa Y; Kohno N
    J Clin Pathol; 2011 Oct; 64(10):875-9. PubMed ID: 21705376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy.
    Murakami N; Mori T; Nakamura S; Yoshimoto S; Honma Y; Ueno T; Kobayashi K; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
    J Radiat Res; 2019 Nov; 60(6):803-811. PubMed ID: 31361893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.
    Zamunér FT; Karia BT; de Oliveira CZ; Santos CR; Carvalho AL; Vettore AL
    Mol Cancer Ther; 2015 Mar; 14(3):828-34. PubMed ID: 25564441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.
    Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y
    Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.